【摘要】：探討參芪扶正注射液治療矽肺合并肺原性心臟病、心力衰竭的療效。將120例矽肺合并肺原性心臟病、心力衰竭患者按心功能級別分為治療組和對照組,對照組采用常規(guī)治療,治療組在常規(guī)治療基礎(chǔ)上加用參芪扶正注射液,療程均為15d。結(jié)果顯示,治療組與對照組比較,能明顯改善病人的臨床癥狀及心功能,總有效率分別為83.3%和58.3%,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。提示,參芪扶正注射液治療矽肺合并肺原性心臟病、心力衰竭安全有效。
[Abstract]:To investigate the effect of Shenqi Fuzheng injection on silicosis complicated with pulmonary heart disease and heart failure. 120 patients with silicosis complicated with pulmonary heart disease were divided into treatment group and control group according to heart function grade. The control group was treated with routine therapy, and the treatment group was treated with Shenqi Fuzheng injection on the basis of routine treatment. The course of treatment was 15 days. The results showed that compared with the control group, the treatment group could significantly improve the clinical symptoms and cardiac function, the total effective rate was 83.3% and 58.3% respectively, the difference was statistically significant (P0.05). It suggests that Shenqi Fuzheng injection is safe and effective in the treatment of silicosis complicated with pulmonary heart disease.
【作者單位】： 河北宣化鋼鐵公司職工醫(yī)院;
【分類號】：R135.2;R541.5;R541.6

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 任澎,程祖亨,馬依彤,鄒立華,湯寶鵬,張愛倫;黃芪注射液對充血性心力衰竭患者的急性血液動力學(xué)效應(yīng)[J];中國中西醫(yī)結(jié)合雜志;1998年08期

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 周亞芬;慢性阻塞性肺病居家護(hù)理探討[J];中醫(yī)藥臨床雜志;2005年01期

2 劉e，

本文編號：2321719